Doctors in Congress question EPA claims on Asthma and Ozone
A group of doctors in Congress have recently sent a letter to the EPA questioning whether the agency’s plan to mandate the reduction of the current ozone standard from 75 ppb to between 65 and 70 ppb will be worth the expected expense. In the letter, the Congressional Reps noted weaknesses in the EPA’s assumptions, arguments, and research methodologies. For example,
- There is no correlation between decreasing ozone levels and asthma rates.
[A]ccording to EPA and the Centers for Disease Control and Prevention, asthma prevalence has increased by 15 percent since 2001, while ozone concentrations have decreased by 18 percent during the same time period.
- The EPA studies used test groups that are too small to obtain accurate results, or results that can be reliably applied to the U.S. population
- Some 430,000 comments received by the EPA demonstrate there is “no certainty” on the proposed rule
- EPA already admits that ozone levels have decreased by one-third since 1980
- A NERA research report on the proposed ozone regulation forecasts costs to the economy of $140 billion per year from 2017 to 2040.